Protective Effects of N-Acetylcysteine, Carvedilol, and Paricalcitol in a Rat Model of Peritoneal Fibrosis
- 24 March 2026
- journal article
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 18 (1) , 43-48
Abstract
Aim: This study aimed to evaluate the potential protective effects of paricalcitol, N-acetylcysteine (NAC), and carvedilol in a rat model of chlorhexidine gluconate–induced peritoneal fibrosis.Material and Methods: Thirty-six female Wistar albino rats were randomized into six groups (n=6 each). Peritoneal fibrosis was induced with daily intraperitoneal chlorhexidine gluconate injections for 21 days. Treatment groups received paricalcitol, NAC, or carvedilol, alone or in combination. Serum TGF-β1 levels and histopathological parameters (peritoneal thickness, fibrosis, inflammation, vascularization) were assessed.Results: Serum TGF-β1 was significantly higher in the chlorhexidine group compared to controls (58.29 ± 4.40 vs. 49.06 ± 2.35 ng/mL, p<0.05). NAC significantly reduced TGF-β1 compared to chlorhexidine alone (46.76 ± 4.79 ng/mL, p<0.05). Peritoneal thickness was markedly increased in the chlorhexidine group (245 ± 27.3 µm vs. 22.3 ± 2.6 µm in controls, p<0.01) but attenuated by NAC (169.8 ± 30.8 µm, p<0.01) and carvedilol (146.5 ± 43.1 µm, p<0.01). Fibrosis and inflammation scores were also reduced in NAC and carvedilol groups (all p<0.05). Paricalcitol alone showed only partial and non-significant effects.Conclusions: NAC demonstrated consistent antifibrotic and anti-inflammatory effects, while carvedilol provided moderate benefit and paricalcitol had limited efficacy. These findings suggest that antioxidant therapy, particularly NAC, may represent a potential strategy for preserving peritoneal membrane integrity, though further studies are warranted.Keywords
Funding Information
- This research received no external funding.
This publication has 25 references indexed in Scilit:
- N-Acetylcysteine Decreases Myocardial Content of Inflammatory Mediators Preventing the Development of Inflammation State and Oxidative Stress in Rats Subjected to a High-Fat DietInternational Journal of Inflammation, 2023
- Transforming growth factor–β in tissue fibrosisJournal of Experimental Medicine, 2020
- Oxidative Stress in Patients Undergoing Peritoneal Dialysis: A Current Review of the LiteratureOxidative Medicine and Cellular Longevity, 2017
- Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefitsPharmacology & Therapeutics, 2014
- Addition of N‐Acetyl Cysteine to Carvedilol Decreases the Incidence of Acute Renal Injury After Cardiac SurgeryClinical Cardiology, 2013
- New therapeutic aspect for carvedilol: Antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damageToxicology and Applied Pharmacology, 2012
- Role of N-acetylcysteine on fibrosis and oxidative stress in cirrhotic ratsArquivos de Gastroenterologia, 2008
- Pathogenesis and treatment of peritoneal membrane failurePediatric Nephrology, 2008
- TGF-β1-mediated fibroblast–myofibroblast terminal differentiation—the role of smad proteinsExperimental Cell Research, 2003
- The influence of ibuprofen on fracture repair: Biomechanical, biochemical, histologic, and histomorphometric parameters in ratsJournal of Orthopaedic Research, 1991